Literature DB >> 1955098

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

M A Gall1, P Rossing, P Skøtt, P Damsbo, A Vaag, K Bech, A Dejgaard, M Lauritzen, E Lauritzen, P Hougaard.   

Abstract

The prevalence of micro- and macroalbuminuria was determined in Type 2 (non-insulin-dependent) diabetic patients, less than 76 years of age, attending a diabetic clinic during 1987. All eligible patients (n = 557) were asked to collect a 24-h urine sample for quantitative albumin analysis. Urine collections were obtained in 296 males and 253 females (96%). Normoalbuminuria were defined as urinary albumin excretion less than or equal to 30 mg/24 h (n = 323), microalbuminuria as 31-299 mg/24 h (n = 151), and macroalbuminuria as greater than or equal to 300 mg/24 h (n = 75). The prevalence of macroalbuminuria was significantly higher in males (20%) than in females (6%), while the prevalence of microalbuminuria was almost identical in males (26%) and females (29%). The prevalence of arterial hypertension increased with increased albuminuria, being 48%, 68%, and 85% in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria respectively. Prevalence of proliferative retinopathy rose with increasing albuminuria, being 2%, 5% and 12% in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria respectively. Prevalence of coronary heart disease, based on Minnesota coded electrocardiograms, was more frequent in patients with macroalbuminuria (46%) compared to patients with microalbuminuria (26%) and patients with normoalbuminuria (22%). Foot ulcers were more frequent in micro- and macroalbuminuric patients, being 13% and 25%, respectively, compared to 5% in patients with normoalbuminuria. This cross-sectional study has revealed a high prevalence of microalbuminuria (27%) and macroalbuminuria (14%) in Type 2 diabetic patients. Patients with raised urinary albumin excretion are characterized by obesity, elevated haemoglobin Alc, increased frequency of arterial hypertension, proliferative retinopathy, coronary heart disease and foot ulcers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955098     DOI: 10.1007/bf00400995

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  [Fully mechanized kinetic measurement of creatinine].

Authors:  R Ullmann; K Bonitz
Journal:  Med Lab (Stuttg)       Date:  1976-06

2.  Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

Authors:  J S Yudkin; R D Forrest; C A Jackson
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Non-insulin-dependent diabetes and renal replacement therapy.

Authors:  A Grenfell; M Bewick; V Parsons; S Snowden; D Taube; P J Watkins
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

4.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

5.  Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case.

Authors:  J Berkman; H Rifkin
Journal:  Metabolism       Date:  1973-05       Impact factor: 8.694

6.  Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan-incidence, risk factors, prognosis and causes of death.

Authors:  A Sasaki; N Horiuchi; K Hasagawa; M Uehara
Journal:  Diabetes Res Clin Pract       Date:  1989-11-06       Impact factor: 5.602

7.  Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians.

Authors:  R G Nelson; C L Kunzelman; D J Pettitt; M F Saad; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

8.  Microalbuminuria and cardiovascular risk factors in type 2 diabetes mellitus.

Authors:  J Allawi; R J Jarrett
Journal:  Diabet Med       Date:  1990-02       Impact factor: 4.359

9.  Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

Authors:  H H Parving; M A Gall; P Skøtt; H E Jørgensen; H Løkkegaard; F Jørgensen; B Nielsen; S Larsen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

View more
  61 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

2.  Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years.

Authors:  M Cahill; A Halley; M Codd; N O'Meara; R Firth; D Mooney; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

Review 3.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 4.  Epidemiology of diabetes and diabetes-related complications.

Authors:  Anjali D Deshpande; Marcie Harris-Hayes; Mario Schootman
Journal:  Phys Ther       Date:  2008-09-18

Review 5.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 6.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

7.  Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA).

Authors:  K Wattanakit; A R Folsom; M H Criqui; H J Kramer; M Cushman; S Shea; A T Hirsch
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

8.  Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients.

Authors:  M Afkhami-Ardekani; M Modarresi; E Amirchaghmaghi
Journal:  Indian J Nephrol       Date:  2008-07

Review 9.  Update on the use of trandolapril in the management of cardiovascular disorders.

Authors:  Ariel Diaz; Anique Ducharme
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.

Authors:  Nikolaos Ostlund Papadogeorgos; Mattias Bengtsson; Majid Kalani
Journal:  Vasc Health Risk Manag       Date:  2009-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.